We are live on
!
Find out more
MCM
Martin Capital Management Portfolio holdings
AUM
$36.5M
1-Year Est. Return
4.02%
This Fund
S&P 500
This Quarter
Est. Return
+6.56%
1 Year Est. Return
-4.02%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$41.7M
AUM Growth
-$3.2M
(-7.1%)
Cap. Flow
-$6.04M
Cap. Flow
% of AUM
-14.5%
Top 10 Holdings %
Top 10 Hldgs %
95.46%
Holding
13
New
–
Increased
–
Reduced
11
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$2.97M |
| 2 |
AbbVie
ABBV
|
+$1.81M |
| 3 |
Gentex
GNTX
|
+$254K |
| 4 |
AT&T
T
|
+$204K |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$200K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 29.89% |
| 2 | Healthcare | 28.74% |
| 3 | Financials | 25.54% |
| 4 | Consumer Staples | 10.22% |
| 5 | Technology | 4.45% |
Similar funds
HCPI
IT
ACM
EI
OHCM
AC
WA
SFCM
Martin Capital Management's Q3 2013 Portfolio in Review
As of Q3 2013, Martin Capital Management held 13 positions worth $41.7M, down 7.1% from $44.9M the previous quarter. Its ten largest holdings account for 95% of the portfolio.
Martin Capital Management withdrew a net $6.04M in Q3 2013, closing 1 position and reducing 11 holdings. Its most notable exit was AT&T, an estimated $204K position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 30% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- Martin Capital Management's biggest Q3 2013 reduction was Amgen, cutting an estimated $2.97M.
- Martin Capital Management fully exited AT&T in Q3 2013, selling an estimated $204K.
- Martin Capital Management's ten largest holdings make up 95% of its $41.7M portfolio in Q3 2013.
- Martin Capital Management opened 0 new positions and closed 1 in Q3 2013.
- Martin Capital Management's portfolio value fell 7.1% quarter-over-quarter to $41.7M.
Based on Martin Capital Management's 13F filing for Q3 2013, filed 5 Nov 2013.